Jian Hua Mo
Direttore/Membro del Consiglio presso HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Patrimonio netto: 173 M $ in data 30/04/2024
Posizioni attive di Jian Hua Mo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Direttore/Membro del Consiglio | 01/05/2012 | - |
| Corporate Officer/Principal | 01/01/2003 | 01/05/2012 | |
| BINJIANG SERVICE GROUP CO. LTD. | Direttore/Membro del Consiglio | 01/12/2017 | - |
| Shanghai Binshun Investment Management Ltd | Direttore/Membro del Consiglio | - | - |
| Hangzhou Binpu Real Estate Development Ltd. | Direttore/Membro del Consiglio | - | - |
| Corporate Officer/Principal | - | - | |
| Hangzhou Pute Equity Investment Management Ltd. | Corporate Officer/Principal | 01/01/2017 | - |
Storia della carriera di Jian Hua Mo
Precedenti posizioni note di Jian Hua Mo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Hangzhou Binjiang Venture Captal Investment Ltd. | Corporate Officer/Principal | 01/05/2011 | 01/11/2017 |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. | Corporate Officer/Principal | 01/08/1996 | 01/12/1999 |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Direttore/Membro del Consiglio | 08/04/2011 | - |
Formazione di Jian Hua Mo
| Zhejiang University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Cina | 9 |
| Isole Cayman | 2 |
Posizioni
| Director/Board Member | 5 |
| Corporate Officer/Principal | 5 |
| Masters Business Admin | 1 |
Settori
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| BINJIANG SERVICE GROUP CO. LTD. | Finance |
| Aziende private | 6 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Shanghai Binshun Investment Management Ltd | |
| Hangzhou Binpu Real Estate Development Ltd. | |
| Hangzhou Pute Equity Investment Management Ltd. | |
| Hangzhou Binjiang Venture Captal Investment Ltd. | |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. |
- Borsa valori
- Insiders
- Jian Hua Mo
- Esperienza
